Before you begin taking a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Onglyza (Saxagliptin).
Blood sugar control: If your body experiences stress such as fever, trauma, infection, or surgery, you may lose control of blood glucose. Your doctor may decide to temporarily stop Onglyza (Saxagliptin) and advise you to take insulin. Talk to your doctor if you have fever, infection, or are about to undergo surgery.
Congestive Heart Failure (CHF): Heart failure has been reported in people taking Onglyza (Saxagliptin). If you have CHF or heart disease, discuss with your doctor how Onglyza (Saxagliptin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Onglyza (Saxagliptin), and whether Onglyza (Saxagliptin) is appropriate for you.
Galactose intolerance/glucose malabsorption: Onglyza (Saxagliptin) is prepared with lactose. If you have lactose or galactose intolerance speak with your doctor about whether Onglyza (Saxagliptin) is appropriate for you.
Hypoglycemia: Onglyza (Saxagliptin) may increase the risk of hypoglycemia (low blood sugar) when taking Onglyza (Saxagliptin) with a sulfonylurea or insulin. If you are taking Onglyza (Saxagliptin) with another medication to reduce blood sugar, your doctor may recommend a lower dose of the other medication.
If you experience low blood sugar (e.g., headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery) contact your doctor.
Immune system: If you have a weakened immune system (e.g., you have had an organ transplant or have HIV), discuss with your doctor how Onglyza (Saxagliptin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Onglyza (Saxagliptin), and whether any special monitoring is needed.
Kidney function: Kidney Disease or reduced kidney function may cause Onglyza (Saxagliptin) to build up in the body, causing side effects. If you have reduced kidney function or kidney disease, discuss with your doctor how Onglyza (Saxagliptin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Onglyza (Saxagliptin), and whether any special monitoring is needed.
Onglyza (Saxagliptin) may also cause reduced kidney function. Your doctor may recommend regular testing to check your kidney function while you are taking Onglyza (Saxagliptin). Onglyza (Saxagliptin) is not recommended for people with end-stage renal disease and those on dialysis.
Liver function: Liver disease or reduced liver function may cause Onglyza (Saxagliptin) to build up in the body, causing side effects. If you have liver problems, discuss with your doctor how Onglyza (Saxagliptin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Onglyza (Saxagliptin), and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Onglyza (Saxagliptin).
Onglyza (Saxagliptin) is not recommended for people with moderately or severely reduced liver function.
Pancreatitis: Onglyza (Saxagliptin) can cause the pancreas to become inflamed. If you have a history of pancreatitis, discuss with your doctor how Onglyza (Saxagliptin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Onglyza (Saxagliptin), and whether any special monitoring is needed.
Report signs of pancreatitis such as abdominal pain on the upper left side, back pain, nausea, fever, chills, rapid heartbeat, or swollen abdomen to your doctor immediately.
Type 1 diabetes and diabetic ketoacidosis: Onglyza (Saxagliptin) should not be used to treat type 1 diabetes, diabetic pre-coma or coma, or diabetic ketoacidosis (increased ketones in the blood or urine).
Pregnancy: Onglyza (Saxagliptin) is not recommended for use during pregnancy. If you become pregnant while taking Onglyza (Saxagliptin), contact your doctor immediately.
Breast-feeding: It is not known if Onglyza (Saxagliptin) passes into breast milk. If you are a breast-feeding mother and are taking Onglyza (Saxagliptin), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Onglyza (Saxagliptin) have not been established for children.
Seniors: People over the age of 65 may be more at risk of developing side effects from Onglyza (Saxagliptin).